Cargando…

Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy

A hybrid 3D bioprinting approach using porous microscaffolds and extrusion-based printing method is presented. Bioink constitutes of cell-laden poly(D,L-lactic-co-glycolic acid) (PLGA) porous microspheres with thin encapsulation of agarose-collagen composite hydrogel (AC hydrogel). Highly porous mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Yu Jun, Tan, Xipeng, Yeong, Wai Yee, Tor, Shu Beng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155425/
https://www.ncbi.nlm.nih.gov/pubmed/27966623
http://dx.doi.org/10.1038/srep39140
_version_ 1782475003110883328
author Tan, Yu Jun
Tan, Xipeng
Yeong, Wai Yee
Tor, Shu Beng
author_facet Tan, Yu Jun
Tan, Xipeng
Yeong, Wai Yee
Tor, Shu Beng
author_sort Tan, Yu Jun
collection PubMed
description A hybrid 3D bioprinting approach using porous microscaffolds and extrusion-based printing method is presented. Bioink constitutes of cell-laden poly(D,L-lactic-co-glycolic acid) (PLGA) porous microspheres with thin encapsulation of agarose-collagen composite hydrogel (AC hydrogel). Highly porous microspheres enable cells to adhere and proliferate before printing. Meanwhile, AC hydrogel allows a smooth delivery of cell-laden microspheres (CLMs), with immediate gelation of construct upon printing on cold build platform. Collagen fibrils were formed in the AC hydrogel during culture at body temperature, improving the cell affinity and spreading compared to pure agarose hydrogel. Cells were proven to proliferate in the bioink and the bioprinted construct. High cell viability up to 14 days was observed. The compressive strength of the bioink is more than 100 times superior to those of pure AC hydrogel. A potential alternative in tissue engineering of tissue replacements and biological models is made possible by combining the advantages of the conventional solid scaffolds with the new 3D bioprinting technology.
format Online
Article
Text
id pubmed-5155425
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51554252016-12-20 Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy Tan, Yu Jun Tan, Xipeng Yeong, Wai Yee Tor, Shu Beng Sci Rep Article A hybrid 3D bioprinting approach using porous microscaffolds and extrusion-based printing method is presented. Bioink constitutes of cell-laden poly(D,L-lactic-co-glycolic acid) (PLGA) porous microspheres with thin encapsulation of agarose-collagen composite hydrogel (AC hydrogel). Highly porous microspheres enable cells to adhere and proliferate before printing. Meanwhile, AC hydrogel allows a smooth delivery of cell-laden microspheres (CLMs), with immediate gelation of construct upon printing on cold build platform. Collagen fibrils were formed in the AC hydrogel during culture at body temperature, improving the cell affinity and spreading compared to pure agarose hydrogel. Cells were proven to proliferate in the bioink and the bioprinted construct. High cell viability up to 14 days was observed. The compressive strength of the bioink is more than 100 times superior to those of pure AC hydrogel. A potential alternative in tissue engineering of tissue replacements and biological models is made possible by combining the advantages of the conventional solid scaffolds with the new 3D bioprinting technology. Nature Publishing Group 2016-12-14 /pmc/articles/PMC5155425/ /pubmed/27966623 http://dx.doi.org/10.1038/srep39140 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Tan, Yu Jun
Tan, Xipeng
Yeong, Wai Yee
Tor, Shu Beng
Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title_full Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title_fullStr Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title_full_unstemmed Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title_short Hybrid microscaffold-based 3D bioprinting of multi-cellular constructs with high compressive strength: A new biofabrication strategy
title_sort hybrid microscaffold-based 3d bioprinting of multi-cellular constructs with high compressive strength: a new biofabrication strategy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155425/
https://www.ncbi.nlm.nih.gov/pubmed/27966623
http://dx.doi.org/10.1038/srep39140
work_keys_str_mv AT tanyujun hybridmicroscaffoldbased3dbioprintingofmulticellularconstructswithhighcompressivestrengthanewbiofabricationstrategy
AT tanxipeng hybridmicroscaffoldbased3dbioprintingofmulticellularconstructswithhighcompressivestrengthanewbiofabricationstrategy
AT yeongwaiyee hybridmicroscaffoldbased3dbioprintingofmulticellularconstructswithhighcompressivestrengthanewbiofabricationstrategy
AT torshubeng hybridmicroscaffoldbased3dbioprintingofmulticellularconstructswithhighcompressivestrengthanewbiofabricationstrategy